Resistance exercise training in middle-aged women targeting blood pressure and vascular health
Active Grant Awarded Last action
- Award ID
- R01MD021869
- Recipient
-
University Of Maryland, College Park UEI NPU8ULVAAS23
- Awarding agency
-
National Institute for Minority Health and Health Disparities
National Institutes of Health, Department of Health and Human Services
- Obligated
- $769,639
Award facts
- Assistance listing
- 93.307 Minority Health and Health Disparities Research
- Completion date 4% complete
- Place of performance
- College Park, MD 20742, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through its National Institute for Minority Health and Health Disparities, awarded the University of Maryland, College Park $769,639 on September 9, 2026 under Grant R01MD021869, with ultimate completion on May 31, 2031. The award is an assistance grant under the Minority Health and Health Disparities Research program (CFDA 93.307), which supports basic, clinical, social, and behavioral research and reaches minority and health disparity communities.
The funded work is a multi-site clinical trial comparing 16 weeks of supervised resistance exercise training against a no-exercise control. The trial enrolls 200 middle-aged women aged 40 to 64 with elevated blood pressure or stage-1 hypertension. Primary and secondary endpoints include 24-hour ambulatory blood pressure, nocturnal dipping patterns, and measures of vascular reactivity and stiffness. The study also evaluates whether menopausal status moderates these effects. The place of performance is College Park, Maryland 20742.
Description
- Abstract
- Hypertension rates increase dramatically in women during midlife, such that ~75% of women >60 have hypertension (HTN). Midlife and corresponding arrival of menopause may expose women to a "double HIT" whereby (I) increases in blood pressure (BP) and (II) compromised vascular health (impaired vascular reactivity, increased vascular stiffness) drastically accelerate HTN development and their risk of later-life CVD and cerebrovascular disease compared to men. There is an urgent need for non-pharmacological interventions to improve midlife BP and vascular health in women since (I) HTN is harder to pharmaceutically control in women than men during midlife, and (II) traditional behavioral interventions (aerobic exercise) fall short of effectively improving vascular health in women following menopause. Our data suggest resistance exercise training may be an underutilized but critical intervention to improve BP trajectories and vascular health in at-risk women during midlife potentially regardless of menopause onset, thereby filling a critical unmet need by current strategies to reduce CVD and cerebrovascular disease risk in women. The central objective of this proposal is to conduct a multi-site clinical trial to investigate the impact of 16 WK supervised resistance exercise training (RET) compared to a no-exercise control (CON) on ambulatory blood pressure and vascular health in 200 representative sample of middle-aged women (40-64 years) with elevated BP or stage-1 HTN. Primary and secondary endpoints will include 24-hour ambulatory BP and nocturnal dipping patterns, as well as measures of vascular reactivity and stiffness. Lastly, the study aims to evaluate the efficacy of RET in improving 24-hour BP and vascular health, and whether menopausal status moderates these effects. This project integrates gold-standard clinical measures of BP and disease risk (ambulatory blood pressure) with novel measures of BP (overnight blood pressure dipping patterns) and vascular health (vascular reactivity and stiffness across parts of the vascular tree mechanistically linked to cardio- and cerebro-vascular disease risk). Understanding whether RET is an effective intervention to target BP and vascular health during midlife in women is critical to improve our ability to prevent HTN and concomitant cardio- and cerebro-vascular disease in women that remains inadequately ameliorated by common pharmaceutical and lifestyle interventions.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $769,639 |
Quick answers
Who received award R01MD021869?
R01MD021869 was awarded to University Of Maryland, College Park by National Institute for Minority Health and Health Disparities (National Institutes of Health) on September 9, 2026.
How much is award R01MD021869 worth?
$769,639 has been obligated on R01MD021869.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award